 |
市場調査レポート
商品コード
1424992
微生物API市場：宿主別、タイプ別、分子別、サイト別、エンドユーザー別、国別、地域別 - 2024年～2032年の産業分析、市場規模、市場シェア、予測Microbial API Market, By Host, By Type, By Molecule, By Site, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
| 微生物API市場：宿主別、タイプ別、分子別、サイト別、エンドユーザー別、国別、地域別 - 2024年～2032年の産業分析、市場規模、市場シェア、予測 |
|
出版日: 2024年02月07日
発行: AnalystView Market Insights
ページ情報: 英文 267 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 図表
- 目次
レポートハイライト
微生物API市場規模は2023年に621億9,600万米ドルとなり、2024年から2032年にかけてCAGR 6.5％で拡大
微生物API市場 - 市場力学
生物学的薬剤に対する需要の高まりと発酵プロセスを利用した市場開拓の容易さが市場成長の原動力となる見込み
生物学的製剤は生物製剤とも呼ばれ、生物またはその成分に由来する医薬品です。これらの医薬品は通常、タンパク質、抗体、核酸などの巨大で複雑な分子であり、がん、自己免疫疾患、感染症など様々な疾患の治療に使用されます。バイオシミラーは数年前から米国食品医薬品局（FDA）により承認されているが、多くのヘルスケア専門家にとってはまだ比較的新しい医薬品であり、特に糖尿病や眼科のようなバイオシミラーが最近承認されたばかりの治療分野では、まだ新しい医薬品です。バイオシミラー業界の専門家によると、バイオシミラーは2025年までに米国の薬剤費を1,330億米ドル削減すると予測されています。微生物APIという用語は、発酵を通じて微生物に由来する医薬品有効成分（API）を指します。これらの微生物APIは生物学的薬剤の主要成分です。さらに、遺伝子工学や発酵技術などのバイオテクノロジーの進歩は、微生物原薬の生産効率を向上させ、技術革新の機会を生み出しています。しかし、規制上の課題や環境への懸念が市場の成長の障害となる可能性があります。
微生物API市場 - 主要インサイト
当社のリサーチアナリストが共有した分析によると、世界の微生物API市場は予測期間（2024年～2032年）に約6.5％のCAGRで毎年成長すると推定されます。
宿主セグメンテーションに基づくと、哺乳類が2023年に最大の市場シェアを示すと予測されました。
タイプ別では、2023年には抗体が主要分子となります。
分子セグメンテーションに基づくと、2023年にはジェネリック医薬品が主要分子でした。
使用サイト別では、2023年は委託製造が主要分子でした。
エンドユーザーセグメンテーションに基づくと、2023年の主要分子は製薬会社でした。
地域別では、アジア太平洋地域が2023年の主要収益源であった
微生物API市場 - セグメンテーション分析：
世界の微生物API市場は、宿主、タイプ、分子、サイト、エンドユーザー、地域に基づいてセグメント化されます。
市場は宿主に基づいて3つのカテゴリーに分けられる：哺乳類、細菌、真菌。市場の成長を牽引しているのは、哺乳類セグメントの優位性です。哺乳類細胞は、がんや自己免疫疾患など多様な疾患の治療に広く応用されているバイオ医薬品の一種であるモノクローナル抗体（mAbs）の製造に広く利用されています。
市場はタイプ別に5つに分類される：抗体、ペプチド、タンパク質、低分子、ワクチンです。抗体セグメントは市場を独占しています。微生物発現システムを使用することで、特定の抗体断片の生産においてコスト面で有利になります。これは、コストへの配慮が重要な役割を果たす製薬業界では特に重要です。
市場は分子によって2つのカテゴリーに分けられる：イノベーティブとジェネリックです。市場成長の主な原動力はジェネリック分子です。ジェネリック医薬品に利用される微生物原薬に関しては、活性成分は微生物発酵によって製造することができます。この方法は、特定の抗生物質やその他の治療用化合物の製造に広く採用されています。
市場は、製造所によって2つのカテゴリーに分けられる：インハウスとアウトソーシングです。アウトソーシング・セグメンテーションが市場を独占しています。微生物発現システムを利用することで、特定の抗体断片を製造する際のコストメリットが得られます。これは、コスト要因が大きな比重を占める製薬分野で特に重要な意味を持っています。
市場はエンドユーザー別に製薬企業、バイオ製薬企業、その他の3つに分類されます。製薬会社が市場で大きなシェアを占めています。微生物原薬分野に従事する企業は、発酵技術やこれらの原薬を製造するためのプロセスの高度化に関する専門知識を有しています。これらの企業は、微生物発酵の有効性を向上させ、新規治療化合物を探索するための研究開発にリソースを頻繁に割り当てています。
微生物API市場 -地理的洞察
この市場は、北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカを含む様々な地域に地理的に広がっています。これらの地域は、事業活動に関与する国に基づいてさらに分割されます。アジア太平洋地域は、主に生命を脅かす疾病の蔓延の増加とヘルスケアインフラの改善により、市場の成長において支配的な役割を果たすと予想されています。この地域は人口が多く多様性に富んでおり、がん、糖尿病、心血管障害などの疾病の発生が増加しています。世界保健機関（WHO）によると、心血管疾患は世界の死因の第1位で、毎年約1,790万人の命を奪っています。アジア太平洋地域の多くの国々は、近代的な病院、診療所、研究機関の設立など、ヘルスケア・インフラに多大な投資を行ってきました。特に中国は、過去20年間でヘルスケア支出が大幅に増加しており、総支出は2021年に7兆6,000億人民元（約1兆2,000億米ドル）に達し、2015年から2倍以上に増加しました。2021年のヘルスケア支出は年間GDPの6.5％を占め、2020年の7.1％より若干低いです。一方、予測期間における市場の成長を牽引するのは北米と欧州と予想され、その主な理由は、地域または地方レベルで強力な製薬会社が存在するためです。
微生物API市場 - 競合情勢：
微生物API市場の競合情勢は、製薬会社、製造受託機関（CMO）、微生物由来の有効成分の生産に携わるその他の事業体間の厳しい競争によって特徴付けられます。この市場では、大手製薬会社はより大きな市場シェアを獲得するために、専門的なCMOと競合することが多いです。この業界における競合は、主に生産技術の革新、プロセスの最適化、新しくユニークな微生物株の開発によって引き起こされています。効率向上と生産コスト削減のための研究開発を優先する企業は、競争優位性を獲得することができます。例えば、ロンザ社は、バイオ医薬品の製造プロセスを強化するため、遺伝子工学に大きな重点を置いています。ロンザ社の微生物開発サービスで菌株開発とセルバンキングの責任者を務めるヨアヒム・クライン氏によると、ゲノム編集、次世代シーケンシング、ゲノミクスの進歩は、生産性が高くスケーラブルな生産菌株を設計する上で重要な役割を果たしています。
目次
第1章 微生物API市場概要
- 調査範囲
- 市場推定年数
第2章 エグゼクティブサマリー
- 市場内訳
- 競合考察
第3章 微生物APIの主要な市場動向
- 市場促進要因
- 市場抑制要因
- 市場機会
- 今後の市場動向
第4章 微生物API産業の調査
- PEST分析
- ポーターのファイブフォース分析
- 成長見通しのマッピング
- 規制枠組みの分析
第5章 微生物API市場：COVID-19症の影響分析
- 新型コロナウイルス感染症以前の影響分析
- 新型コロナウイルス感染症後の影響分析
第6章 微生物API市場情勢
- 微生物API市場シェア分析、2023年
- 主要メーカー別の内訳データ
- 既存企業の分析
- 新興企業の分析
第7章 微生物API市場 - 宿主別
- 概要
- 宿主別のセグメントシェア分析
- 哺乳類
- 細菌性
- 真菌
第8章 微生物API市場 - タイプ別
- 概要
- タイプ別セグメントシェア分析
- 抗体
- ペプチド
- タンパク質
- 低分子
- ワクチン
第9章 微生物API市場 - 分子別
- 概要
- 分子別のセグメントシェア分析
- 革新的
- ジェネリック
第10章 微生物API市場 - サイト別
- 概要
- セグメントシェア分析（サイト別）
- 社内
- 外部委託
第11章 微生物API市場 - エンドユーザー別
- 概要
- エンドユーザー別のセグメントシェア分析
- 製薬会社
- バイオ医薬品企業
- その他
第12章 微生物API市場 - 地域別
- イントロダクション
- 北米
- 概要
- 北米の主要メーカー
- 米国
- カナダ
- 欧州
- 概要
- 欧州の主要メーカー
- ドイツ
- イタリア
- 英国
- フランス
- ロシア
- オランダ
- スウェーデン
- ポーランド
- その他
- アジア太平洋（APAC）
- 概要
- アジア太平洋の主要メーカー
- インド
- 中国
- 日本
- 韓国
- オーストラリア
- タイ
- インドネシア
- フィリピン
- その他
- ラテンアメリカ
- 概要
- ラテンアメリカの主要メーカー
- ブラジル
- メキシコ
- アルゼンチン
- コロンビア
- その他
- 中東・アフリカ
- 概要
- 中東・アフリカの主要メーカー
- サウジアラビア
- アラブ首長国連邦
- イスラエル
- トルコ
- アルジェリア
- エジプト
- その他
第13章 主要ベンダー分析 - 微生物API業界
- 競合ダッシュボード
- 企業プロファイル
- Merck &Co., Inc.
- Topfond Pharmaceutical Co., Ltd.
- DSM
- CSPC Pharmaceutical Group Limited
- KOLON LIFE SCIENCE
- Shandong Lukang Pharmaceutical Co., Ltd.
- Teva Pharmaceutical Industries Ltd.
- Lonza
- Others
第14章 アナリストの全方位展望
List of Tables
- TABLE List of data sources
- TABLE Market drivers; Impact Analysis
- TABLE Market restraints; Impact Analysis
- TABLE Microbial API Market: Host Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Host
- TABLE Global Microbial API Market, by Host 2019-2032 (USD Million)
- TABLE Microbial API Market: Type Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Type
- TABLE Global Microbial API Market, by Type 2019-2032 (USD Million)
- TABLE Microbial API Market: Molecule Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Molecule
- TABLE Global Microbial API Market, by Molecule 2019-2032 (USD Million)
- TABLE Microbial API Market: Site Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Site
- TABLE Global Microbial API Market, by Site 2019-2032 (USD Million)
- TABLE Microbial API Market: End User Snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by End User
- TABLE Global Microbial API Market, by End User 2019-2032 (USD Million)
- TABLE Microbial API Market: Regional snapshot (2023)
- TABLE Segment Dashboard; Definition and Scope, by Region
- TABLE Global Microbial API Market, by Region 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by Country, 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by Host, 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by Type, 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by Molecule, 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by Site, 2019-2032 (USD Million)
- TABLE North America Microbial API Market, by End User, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by Country, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by Host, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by Type, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by Molecule, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by Site, 2019-2032 (USD Million)
- TABLE Europe Microbial API Market, by End User, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by Country, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by Host, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by Type, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by Molecule, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by Site, 2019-2032 (USD Million)
- TABLE Asia Pacific Microbial API Market, by End User, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by Country, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by Host, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by Type, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by Molecule, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by Site, 2019-2032 (USD Million)
- TABLE Latin America Microbial API Market, by End User, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by Country, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by Host, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by Type, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by Molecule, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by Site, 2019-2032 (USD Million)
- TABLE Middle East and Africa Microbial API Market, by End User, 2019-2032 (USD Million)
List of Figures
- FIGURE Microbial API Market Segmentation
- FIGURE Market research methodology
- FIGURE Value chain analysis
- FIGURE Porter's Five Forces Analysis
- FIGURE Market Attractiveness Analysis
- FIGURE COVID-19 Impact Analysis
- FIGURE Pre & Post COVID-19 Impact Comparision Study
- FIGURE Competitive Landscape; Key company market share analysis, 2023
- FIGURE Host segment market share analysis, 2023 & 2032
- FIGURE Host segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Type segment market share analysis, 2023 & 2032
- FIGURE Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Molecule segment market share analysis, 2023 & 2032
- FIGURE Molecule segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Site segment market share analysis, 2023 & 2032
- FIGURE Site segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE End User segment market share analysis, 2023 & 2032
- FIGURE End User segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Regional segment market share analysis, 2023 & 2032
- FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE North America Microbial API Market share and leading players, 2023
- FIGURE Europe Microbial API Market share and leading players, 2023
- FIGURE Asia Pacific Microbial API Market share and leading players, 2023
- FIGURE Latin America Microbial API Market share and leading players, 2023
- FIGURE Middle East and Africa Microbial API Market share and leading players, 2023
- FIGURE North America market share analysis by country, 2023
- FIGURE U.S. Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Canada Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Europe Microbial API Market share analysis by country, 2023
- FIGURE Germany Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Spain Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Italy Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE France Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE UK Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Russia Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Netherlands Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Sweden Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Poland Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of the Europe Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Asia Pacific Microbial API Market share analysis by country, 2023
- FIGURE India Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE China Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Japan Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE South Korea Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Australia Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Thailand Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Indonesia Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Phillipines Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of APAC Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Latin America Microbial API Market share analysis by country, 2023
- FIGURE Brazil Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Mexico Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Argentina Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Colombia Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of LATAM Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Middle East and Africa Microbial API Market share analysis by country, 2023
- FIGURE Saudi Arabia Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE United Arab Emirates Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Israel Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Turkey Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Algeria Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Egypt Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
- FIGURE Rest of MEA Microbial API Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
REPORT HIGHLIGHT
Microbial API Market size was valued at USD 62,196 Million in 2023, expanding at a CAGR of 6.5% from 2024 to 2032.
Microbial APIs are pharmaceutical substances obtained from microorganisms, including bacteria, fungi, or yeast. In the pharmaceutical field, the term API refers to the active ingredient in a medication that produces the desired therapeutic effect. When referring to Microbial APIs, it generally pertains to pharmaceutical products or drugs derived from microorganisms. An example of this is the production of antibiotics by microorganisms. To demonstrate, the API range provides a standardized and concise version of existing identification techniques. Previously, these techniques were involved to execute and challenging to interpret. In the case of the API 20E, a plastic strip comprises twenty mini-test chambers with dehydrated media that possess chemically-defined compositions for each test. These tests primarily detect enzymatic activity, particularly associated with the fermentation of carbohydrates or the breakdown of proteins or amino acids by the microorganisms under examination.
Microbial API Market- Market Dynamics
The rising demand for biological drugs and the ease of their development using the fermentation process are expected to drive the growth of market
Biological drugs, also known as biologics, are pharmaceutical products that are derived from living organisms or their components. These drugs are typically large and complex molecules, such as proteins, antibodies, or nucleic acids, and they are used to treat various diseases, including cancer, autoimmune disorders, and infectious diseases. While biosimilars have been approved by the U.S. Food and Drug Administration (FDA) for several years now, they are still relatively new to many healthcare professionals, especially in therapeutic areas like diabetes and ophthalmology where biosimilars have only recently received approval. According to Biosimilars industry specialists, biosimilars are projected to reduce U.S. drug expenditure by USD 133 billion by 2025. The term Microbial API refers to the active pharmaceutical ingredients (APIs) that are derived from microorganisms through fermentation. These Microbial APIs are the key components of biological drugs. Furthermore, advancements in biotechnology, such as genetic engineering and fermentation technology, are improving the production efficiency of Microbial APIs and creating opportunities for innovation. However, regulatory challenges and environmental concerns may pose obstacles to the growth of the market.
Microbial API Market- Key Insights
As per the analysis shared by our research analyst, the global Microbial API market is estimated to grow annually at a CAGR of around 6.5% over the forecast period (2024-2032)
Based on Host segmentation, Mammalian was predicted to show maximum market share in the year 2023
Based on Type segmentation, Antibody was the leading Molecule in 2023
Based on Molecule segmentation, Generic was the leading Molecule in 2023
Based on Site segmentation, Outsourced was the leading Molecule in 2023
Based on end user segmentation, Pharmaceutical corporations was the leading Molecule in 2023
On the basis of region, Asia pacific was the leading revenue generator in 2023
Microbial API Market- Segmentation Analysis:
The Global Microbial API Market is segmented on the basis of Host, Type, Molecule, Site, End User, and Region.
The market is divided into three categories based on Host: Mammalian, Bacterial and Fungal. The market growth is driven by the dominance of mammalian segment. Mammalian cells are extensively utilized in the manufacturing of monoclonal antibodies (mAbs), a type of biopharmaceuticals that find widespread application in the treatment of diverse diseases such as cancer and autoimmune disorders.
The market is divided into five categories based on Type: Antibody, Peptide, Protein, Small Molecule and Vaccine. Antibody segment dominates the market. The use of microbial expression systems can offer cost advantages in the production of certain antibody fragments. This is particularly important in the pharmaceutical industry, where cost considerations play a significant role.
The market is divided into two categories based on Molecule: Innovative and Generic. The market growth is predominantly driven by a generic molecule. When it comes to Microbial APIs utilized in generic medications, the active component can be manufactured via microbial fermentation. This method is widely employed in the production of specific antibiotics and other therapeutic compounds.
The market is divided into two categories based on Site: In-House and Outsourced. Outsourced segment dominates the market. The utilization of microbial expression systems can provide cost benefits in manufacturing specific antibody fragments. This holds particular significance in the pharmaceutical sector, where cost factors hold substantial importance.
The market is divided into three categories based on End-User: Pharmaceutical Companies, Bio pharmaceutical Companies and Others. Pharmaceutical corporations hold a significant share in the market. Companies engaged in the Microbial API sector possess expertise in fermentation technology and the advancement of processes for manufacturing these APIs. These corporations frequently allocate resources towards research and development to improve the effectiveness of microbial fermentation and explore novel therapeutic compounds.
Microbial API Market- Geographical Insights
This market is geographically spread across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The Asia Pacific region is expected to have a dominant role in the market's growth, primarily due to the increasing prevalence of life-threatening diseases and the improvement of healthcare infrastructure. This region is home to a large and diverse population, and there is a rising occurrence of diseases such as cancer, diabetes, and cardiovascular disorders. According to the World Health Organization, cardiovascular diseases are the leading cause of death globally, claiming approximately 17.9 million lives each year. Many countries in the Asia Pacific region have made significant investments in healthcare infrastructure, including the establishment of modern hospitals, clinics, and research institutions. China, in particular, has witnessed substantial growth in healthcare spending over the past two decades, with total expenditure reaching RMB 7.6 trillion (approximately US$1.2 trillion) in 2021, more than doubling from 2015. In 2021, healthcare expenditure accounted for 6.5 percent of the annual GDP, slightly lower than the 7.1 percent recorded in 2020. On the other hand, the growth of the market in the forecast period is expected to be driven by North America and Europe, primarily due to the presence of strong pharmaceutical companies at the local or regional level.
Microbial API Market- Competitive Landscape:
The competitive landscape of the Microbial API market is characterized by severe competition among pharmaceutical companies, contract manufacturing organizations (CMOs), and other entities involved in the production of microbial-derived active ingredients. In this market, major pharmaceutical companies often find themselves competing with specialized CMOs to gain a larger market share. The competition in this industry is primarily driven by innovation in production technologies, process optimization, and the development of new and unique microbial strains. Companies that prioritize research and development to improve efficiency and reduce production costs are able to gain a competitive edge. For instance, Lonza has placed significant emphasis on genetic engineering to enhance its processes for the production of biotherapeutics. According to Joachim Klein, the head of strain development and cell banking for Lonza's microbial development services, advancements in genome editing, next-generation sequencing, and genomics play a crucial role in designing productive and scalable production strains.
Recent Developments:
In July 2023, Kinvan Private Limited, the first API fermentation unit, was set up in the Plassara Industrial Area of Nalagarh with an investment of USD 55.2 million (Rs 460 crore) to promote domestic manufacturing in India.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL MICROBIAL API MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
Merck & Co., Inc.
Topfond Pharmaceutical Co., Ltd.
DSM
CSPC Pharmaceutical Group Limited
KOLON LIFE SCIENCE
Shandong Lukang Pharmaceutical Co., Ltd.
Teva Pharmaceutical Industries Ltd.
Lonza
Others
GLOBAL MICROBIAL API MARKET, BY HOST- MARKET ANALYSIS, 2019 - 2032
- Mammalian
- Bacterial
- Fungal
GLOBAL MICROBIAL API MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032
- Antibody
- Peptide
- Protein
- Small Molecule
- Vaccine
GLOBAL MICROBIAL API MARKET, BY MOLECULE- MARKET ANALYSIS, 2019 - 2032
- Innovative
- Generic
GLOBAL MICROBIAL API MARKET, BY SITE- MARKET ANALYSIS, 2019 - 2032
- In-House
- Outsourced
GLOBAL MICROBIAL API MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032
- Pharmaceutical Companies
- Biopharmaceutical Companies
- Others
GLOBAL MICROBIAL API MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Russia
- Netherlands
- Sweden
- Poland
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Australia
- Thailand
- Indonesia
- Philippines
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
Table of Contents
1. Microbial API Market Overview
- 1.1. Study Scope
- 1.2. Market Estimation Years
2. Executive Summary
- 2.1. Market Snippet
- 2.1.1. Microbial API Market Snippet by Host
- 2.1.2. Microbial API Market Snippet by Type
- 2.1.3. Microbial API Market Snippet by Molecule
- 2.1.4. Microbial API Market Snippet by Site
- 2.1.5. Microbial API Market Snippet by End User
- 2.1.6. Microbial API Market Snippet by Country
- 2.1.7. Microbial API Market Snippet by Region
- 2.2. Competitive Insights
3. Microbial API Key Market Trends
- 3.1. Microbial API Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
- 3.2. Microbial API Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
- 3.3. Microbial API Market Opportunities
- 3.4. Microbial API Market Future Trends
4. Microbial API Industry Study
- 4.1. PEST Analysis
- 4.2. Porter's Five Forces Analysis
- 4.3. Growth Prospect Mapping
- 4.4. Regulatory Framework Analysis
5. Microbial API Market: COVID-19 Impact Analysis
- 5.1. Pre-COVID-19 Impact Analysis
- 5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments
6. Microbial API Market Landscape
- 6.1. Microbial API Market Share Analysis, 2023
- 6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis
7. Microbial API Market - By Host
- 7.1. Overview
- 7.1.1. Segment Share Analysis, By Host, 2023 & 2032 (%)
- 7.1.2. Mammalian
- 7.1.3. Bacterial
- 7.1.4. Fungal
8. Microbial API Market - By Type
- 8.1. Overview
- 8.1.1. Segment Share Analysis, By Type, 2023 & 2032 (%)
- 8.1.2. Antibody
- 8.1.3. Peptide
- 8.1.4. Protein
- 8.1.5. Small Molecule
- 8.1.6. Vaccine
9. Microbial API Market - By Molecule
- 9.1. Overview
- 9.1.1. Segment Share Analysis, By Molecule, 2023 & 2032 (%)
- 9.1.2. Innovative
- 9.1.3. Generic
10. Microbial API Market - By Site
- 10.1. Overview
- 10.1.1. Segment Share Analysis, By Site, 2023 & 2032 (%)
- 10.1.2. In-House
- 10.1.3. Outsourced
11. Microbial API Market - By End User
- 11.1. Overview
- 11.1.1. Segment Share Analysis, By End User, 2023 & 2032 (%)
- 11.1.2. Pharmaceutical Companies
- 11.1.3. Biopharmaceutical Companies
- 11.1.4. Others
12. Microbial API Market- By Geography
- 12.1. Introduction
- 12.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
- 12.2. North America
- 12.2.1. Overview
- 12.2.2. Microbial API Key Manufacturers in North America
- 12.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.2.4. North America Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.2.5. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.6. North America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.2.7. North America Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.2.8. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.9. U.S.
- 12.2.9.1. Overview
- 12.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.9.3. U.S. Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.2.9.4. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.9.5. U.S. Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.2.9.6. U.S. Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.2.9.7. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.2.10. Canada
- 12.2.10.1. Overview
- 12.2.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.2.10.3. Canada Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.2.10.4. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.2.10.5. Canada Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.2.10.6. Canada Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.2.10.7. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3. Europe
- 12.3.1. Overview
- 12.3.2. Microbial API Key Manufacturers in Europe
- 12.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.3.4. Europe Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.5. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.6. Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.7. Europe Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.8. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.9. Germany
- 12.3.9.1. Overview
- 12.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.9.3. Germany Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.9.4. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.9.5. Germany Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.9.6. Germany Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.9.7. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.10. Italy
- 12.3.10.1. Overview
- 12.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.10.3. Italy Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.10.4. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.10.5. Italy Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.10.6. Italy Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.10.7. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.11. United Kingdom
- 12.3.11.1. Overview
- 12.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.11.3. United Kingdom Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.11.4. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.11.5. United Kingdom Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.11.6. United Kingdom Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.11.7. United Kingdom Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.12. France
- 12.3.12.1. Overview
- 12.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.12.3. France Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.12.4. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.12.5. France Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.12.6. France Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.12.7. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.13. Russia
- 12.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.13.2. Russia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.13.3. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.13.4. Russia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.13.5. Russia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.13.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.14. Netherlands
- 12.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.14.2. Netherlands Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.14.3. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.14.4. Netherlands Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.14.5. Netherlands Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.14.6. Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.15. Sweden
- 12.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.15.2. Sweden Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.15.3. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.15.4. Sweden Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.15.5. Sweden Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.15.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.16. Poland
- 12.3.16.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.16.2. Poland Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.16.3. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.16.4. Poland Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.16.5. Poland Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.3.17. Rest of Europe
- 12.3.17.1. Overview
- 12.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.3.17.3. Rest of the Europe Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.3.17.4. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.3.17.5. Rest of the Europe Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.3.17.6. Rest of the Europe Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.3.17.7. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4. Asia Pacific (APAC)
- 12.4.1. Overview
- 12.4.2. Microbial API Key Manufacturers in Asia Pacific
- 12.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.4.4. Asia Pacific Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.5. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.6. Asia Pacific Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.7. Asia Pacific Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.8. Asia Pacific Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.9. India
- 12.4.9.1. Overview
- 12.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.9.3. India Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.9.4. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.9.5. India Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.9.6. India Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.9.7. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.10. China
- 12.4.10.1. Overview
- 12.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.10.3. China Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.10.4. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.10.5. China Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.10.6. China Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.10.7. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.11. Japan
- 12.4.11.1. Overview
- 12.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.11.3. Japan Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.11.4. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.11.5. Japan Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.11.6. Japan Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.11.7. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.12. South Korea
- 12.4.12.1. Overview
- 12.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.12.3. South Korea Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.12.4. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.12.5. South Korea Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.12.6. South Korea Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.12.7. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.13. Australia
- 12.4.13.1. Overview
- 12.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.13.3. Australia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.13.4. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.13.5. Australia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.13.6. Australia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.13.7. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.14. Thailand
- 12.4.14.1. Overview
- 12.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.14.3. Thailand Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.14.4. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.14.5. Thailand Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.14.6. Thailand Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.14.7. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.15. Indonesia
- 12.4.15.1. Overview
- 12.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.15.3. Indonesia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.15.4. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.15.5. Indonesia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.15.6. Indonesia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.15.7. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.16. Philippines
- 12.4.16.1. Overview
- 12.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.16.3. Philippines Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.16.4. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.16.5. Philippines Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.16.6. Philippines Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.16.7. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.4.17. Rest of APAC
- 12.4.17.1. Overview
- 12.4.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.4.17.3. Rest of APAC Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.4.17.4. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.4.17.5. Rest of APAC Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.4.17.6. Rest of APAC Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.4.17.7. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5. Latin America
- 12.5.1. Overview
- 12.5.2. Microbial API Key Manufacturers in Latin America
- 12.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.5.4. Latin America Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.5. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.6. Latin America Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.7. Latin America Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.8. Latin America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.9. Brazil
- 12.5.9.1. Overview
- 12.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.9.3. Brazil Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.9.4. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.9.5. Brazil Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.9.6. Brazil Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.9.7. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.10. Mexico
- 12.5.10.1. Overview
- 12.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.10.3. Mexico Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.10.4. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.10.5. Mexico Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.10.6. Mexico Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.10.7. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.11. Argentina
- 12.5.11.1. Overview
- 12.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.11.3. Argentina Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.11.4. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.11.5. Argentina Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.11.6. Argentina Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.11.7. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.12. Colombia
- 12.5.12.1. Overview
- 12.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.12.3. Colombia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.12.4. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.12.5. Colombia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.12.6. Colombia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.12.7. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.5.13. Rest of LATAM
- 12.5.13.1. Overview
- 12.5.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.5.13.3. Rest of LATAM Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.5.13.4. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.5.13.5. Rest of LATAM Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.5.13.6. Rest of LATAM Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.5.13.7. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6. Middle East and Africa
- 12.6.1. Overview
- 12.6.2. Microbial API Key Manufacturers in Middle East and Africa
- 12.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 12.6.4. Middle East and Africa Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.5. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.6. Middle East and Africa Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.7. Middle East and Africa Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.8. Middle East and Africa Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.9. Saudi Arabia
- 12.6.9.1. Overview
- 12.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.9.3. Saudi Arabia Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.9.4. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.9.5. Saudi Arabia Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.9.6. Saudi Arabia Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.9.7. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.10. United Arab Emirates
- 12.6.10.1. Overview
- 12.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.10.3. United Arab Emirates Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.10.4. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.10.5. United Arab Emirates Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.10.6. United Arab Emirates Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.10.7. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.11. Israel
- 12.6.11.1. Overview
- 12.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.11.3. Israel Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.11.4. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.11.5. Israel Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.11.6. Israel Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.11.7. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.12. Turkey
- 12.6.12.1. Overview
- 12.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.12.3. Turkey Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.12.4. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.12.5. Turkey Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.12.6. Turkey Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.12.7. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.13. Algeria
- 12.6.13.1. Overview
- 12.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.13.3. Algeria Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.13.4. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.13.5. Algeria Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.13.6. Algeria Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.13.7. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.14. Egypt
- 12.6.14.1. Overview
- 12.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.14.3. Egypt Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.14.4. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.14.5. Egypt Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.14.6. Egypt Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.14.7. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
- 12.6.15. Rest of MEA
- 12.6.15.1. Overview
- 12.6.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
- 12.6.15.3. Rest of MEA Market Size and Forecast, By Host, 2019 - 2032 (US$ Million)
- 12.6.15.4. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
- 12.6.15.5. Rest of MEA Market Size and Forecast, By Molecule, 2019 - 2032 (US$ Million)
- 12.6.15.6. Rest of MEA Market Size and Forecast, By Site, 2019 - 2032 (US$ Million)
- 12.6.15.7. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
13. Key Vendor Analysis- Microbial API Industry
- 13.1. Competitive Dashboard
- 13.2. Company Profiles
- 13.2.1. Merck & Co., Inc.
- 13.2.2. Topfond Pharmaceutical Co., Ltd.
- 13.2.3. DSM
- 13.2.4. CSPC Pharmaceutical Group Limited
- 13.2.5. KOLON LIFE SCIENCE
- 13.2.6. Shandong Lukang Pharmaceutical Co., Ltd.
- 13.2.7. Teva Pharmaceutical Industries Ltd.
- 13.2.8. Lonza
- 13.2.9. Others
14. 360 Degree Analyst View
15. Appendix
- 15.1. Research Methodology
- 15.2. References
- 15.3. Abbreviations
- 15.4. Disclaimer
- 15.5. Contact Us
